AZNNEUTRAL

Gross Margin

82.5%

Higher than 80% of Healthcare sector peers

Updated 19h ago

Sector Performance

80th percentile

AZN

82.5%

Sector Median

68.9%

Sector Avg

-20.2%

📊

Deep Analysis

AstraZeneca’s gross margin of 82.5% means that for every dollar of revenue, the company keeps 82.5 cents after covering the direct costs of producing its drugs—a measure of core profitability.

This figure sits well above the healthcare sector median of 68.9%, placing AstraZeneca in the 80th percentile among its peers, indicating it earns a wider profit margin than most competitors. The metric shows no trend direction over the last eight quarters, and both the year-over-year and quarter-over-quarter changes are listed as N/A, so there is no basis to assess whether margins are improving or deteriorating. The combination of a high current level with an absent trend suggests that while the margin strength is a clear positive, the lack of historical movement offers no additional insight into momentum or risk. This high gross margin supports the overall NEUTRAL verdict—it confirms financial stability but, without trend data, does not create a compelling case for either a bullish or bearish shift.

Frequently Asked Questions

What does the Gross Margin tell investors about AZN?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does AZN's Gross Margin compare to its sector?

AZN's Gross Margin of 82.5% compares to a Healthcare sector median of 68.9%, placing it in the 80th percentile.

Who are AZN's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: AMGN (68.2%), TDOC (67.8%), TECH (66.9%), NTRA (64.8%), RMD (62.2%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.